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Background
Elective total joint replacement surgery is one of the
most commonly performed procedures in the U.S. In
2014 alone, 370,770 total hip arthroplasty (THA) and
680,150 total knee arthroplasty (TKA) procedures were
performed. Given this high volume, it is important to
have successful wound closure and healing. However,
current literature is unclear about the optimal wound
closure method for arthroplasty.
Skin stapling is the current gold standard for wound
closure of THA and TKA. The FDA-approved
Dermabond Prineo Skin Closure System by Ethicon
(Prineo) can be used as an alternative to skin staples to
help provide strength, flexibility, and antimicrobial
protection.
Little evidence exists evaluating the clinical outcomes
among orthopedic patients who receive the Prineo
compared to those who receive staples for skin closure.
This study aims to retrospectively evaluate whether the
use of Prineo influences clinical outcomes for patients
undergoing elective total joint arthroplasty compared to
skin staples.

Problem Statement
Compared to skin staples, the Prineo would
be associated with fewer complications of
wound healing and well-managed wound pain
after elective THA or TKA.

Methods
A retrospective chart review was conducted for
patients who underwent THA and/or TKA by a
single surgeon between September 2016 and
December 2017 at Lehigh Valley Health Network.
A total of 522 patients was identified and included
in this study.
Clinical characteristics collected from chart review
included the following: age, sex, surgical
procedure, laterality, skin closure device,
discharge disposition, as well as smoking status,
BMI, and diagnosis of diabetes at time of surgery.
Outcome measures included post-operative length
of stay (LOS), pre- and post-operative pain
scores, wound complication rate including surgical
site infection (SSI), intra-operative wound closure
time, and 30-, 60-, and 90-day readmission rates.
In both clinical cohort, subcutaneous layers were
closed with 2-0 absorbable sutures to approximate
skin edges, while the wound was dressed with a
surgical dressing. Ethicon disposable skin stapler
and the Prineo device were used for skin closure.
Staples were removed 2 weeks post-operatively.
Statistical analysis was performed using SPSS 25.

Results

Discussion

Patient characteristics are outlined in Table 1.
Table 1: Patient Characteristics

Total patients
Age (median, range)
Males (n, %)
Females (n, %)
Primary TKA (n, %)
Primary THA (n, %)
Revision TKA/THA
Right extremity surgery
Left extremity surgery
Bilateral extremity surgery
Home Health discharge disposition
SNF discharge disposition
Rehab Facility discharge disposition
Home discharge disposition

Staples
256
66 (19-89)
96 (38)
160 (62)
161 (63)
77 (30)
18 (7)
122 (48)
122 (48)
12 (4)
188 (73)
46 (18)
19 (7)
4 (2)

Use of the Prineo for wound closure was associated with
clinical benefits of shorter LOS, reduced 30-day readmission
rates, and greater rates of reduced post-operative pain
score. Literature research also showed higher patient
satisfaction with the Prineo likely due to the following
reasons: ease of self-care, less pain on removal, ability to
shower immediately following surgery, and greater cosmetic
satisfaction with scar appearance.

Prineo
266
67 (36-90)
99 (37)
167 (63)
165 (62)
89 (33)
12 (5)
131 (49)
117 (44)
18 (7)
192 (72)
54 (20)
12 (5)
8 (3)

Fewer wound complications seen in the Prineo can be
attributed to antimicrobial properties of 2-octylcyanoacrylate.
Reducing risk of infection can lead to substantial economic
benefits. A 90-day economic model based on 500 annual hip
and knee arthroplasty procedures estimated $56.70 to
$79.62 cost savings per patient with 60% uptake of the
Prineo. This estimate is roughly translated to an annual
hospital savings of $28,349 to $39,809.
A single-surgeon, a single-center study design may have
affected the findings seen in this research. Patients were
also evaluated by multiple healthcare providers after
discharge from hospital, leading to potential inconsistencies
in clinical assessment of wound healing and complications.
Although the baseline patient characteristics for both groups
were similar and optimized prior to procedures, patient
factors following their discharge such as wound care could
have significantly altered the clinical outcome measures.
Considering these limitations, further studies involving
multiple surgeons are required to guide clinical practice in
total hip and knee arthroplasty.

While LOS appears to be equivocal between the
two groups, the use of Prineo was associated with
significant decrease in length of hospitalization (1.9
versus 2.1, p=0.01). The use of the Prineo was also
associated with reduced 30-day readmission rate
when compared to the staples cohort (1.5% versus
5.1%, p=0.02). 60-day and 90-day readmission
rates were comparable between the two groups as
seen in Table 2. Patients receiving the Prineo
showed greater rates of reduced post-operative
pain scores when compared to the staples cohort
(25% versus 18%, p=0.05).

Conclusion

Table 2: Outcome Measures

Staples Prineo
2.1
1.9

Average LOS (days)

p-value
0.01

30-day readmission rates (%)

5.1

1.5

0.02

60-day readmission rates (%)

0.8

1.1

0.72

90-day readmission rates (%)

1.2

0.8

0.65

Reduced postoperative pain (%)

25

18

0.05

Average intraoperative closure
time (minutes)
SSI rate (%)

28

30

0.07

0.4

0.0

0.30

Wound complication rate (%)

1.2

0.4

0.30

Although not statistically significant, patients in the
Prineo cohort had lower SSI rates compared to the
staples cohort (0.4% versus 1.2%). One patient in
the Prineo cohort suffered a superficial wound
complication, while 3 patients in the staples group
suffered wound complications (2 superficial and 1
acquired SSI requiring operative irrigation and
debridement with poly-exchange). All superficial
wound complications required treatment with
cephalexin and were resolved by week 6. No wound
dehiscence was reported. Patient characteristics for
wound complications are outlined in Table 3.
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Table 3: Patient Characteristics with Wound Complications

Gender (n, %)
Male
Female
Age (median, range)
Surgical procedure (n, %)
TKA
THA
Revision (n, %)
Diabetes mellitus (n, %)
Smoking (n, %)
Obesity (n, %)

Current literature does not provide clear
guidelines for skin closure in THA and TKA. In
this study, use of the Prineo was associated
with clinical benefits such as decreased LOS,
30-day hospital readmission, and wound pain
compared to skin staples. However, there was
no significant difference in readmission rate
beyond 30 days post-discharge, as well as in
skin closure time, SSI, and wound
complication between the Prineo and staples.
Further studies involving multiple orthopedic
surgeons across regions may help validate
our findings and recommend optimal wound
closure method in arthroplasty procedures.
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